T Cell Inactivation by Poxviral B22 Family Proteins Increases Viral Virulence

PLoS Pathogens

Volumn 10, Issue 5, 2014, Pages

  Alzhanova, Dina ^a   Hammarlund, Erika ^a   Reed, Jason ^a   Meermeier, Erin ^b,c   Rawlings, Stephanie ^a   Ray, Caroline A ^d   Edwards, David M ^a   Bimber, Ben ^a   Legasse, Alfred ^a   Planer, Shannon ^a   Sprague, Jerald ^a   Axthelm, Michael K ^a   Pickup, David J ^d   Lewinsohn, David M ^b,c   Gold, Marielle C ^b,c   Wong, Scott W ^a   Sacha, Jonah B ^a   Slifka, Mark K ^a   Früh, Klaus ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CHLOROCEBUS AETHIOPS; CHO CELL LINE; CRICETULUS; FEMALE; GENETICS; HAMSTER; HEK293 CELL LINE; HUMAN; IMMUNE EVASION; IMMUNOLOGY; JURKAT CELL LINE; MONKEYPOX; MOUSE; PATHOGENICITY; PHYSIOLOGY; POXVIRIDAE; POXVIRUS INFECTION; RHESUS MONKEY; T LYMPHOCYTE; VIROLOGY;

ANIMALS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CHO CELLS; CRICETINAE; CRICETULUS; FEMALE; HEK293 CELLS; HUMANS; IMMUNE EVASION; JURKAT CELLS; MACACA MULATTA; MICE; MICE, INBRED BALB C; MONKEYPOX; POXVIRIDAE; POXVIRIDAE INFECTIONS; T-LYMPHOCYTES; VIRAL PROTEINS;

EID: 84901679086     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004123     Document Type: Article

References (60)

1. Gross E, (2003) Update on emerging infections: news from the Centers for Disease Control and prevention. Update: Multistate outbreak of monkeypox-Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. Ann Emerg Med 42: 660-662 discussion 662-664.
2. Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, et al. (2005) A tale of two clades: monkeypox viruses. J Gen Virol 86: 2661-2672.
3. Chen N, Li G, Liszewski MK, Atkinson JP, Jahrling PB, et al. (2005) Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology 340: 46-63.
4. Hutson CL, Olson VA, Carroll DS, Abel JA, Hughes CM, et al. (2009) A prairie dog animal model of systemic orthopoxvirus disease using West African and Congo Basin strains of monkeypox virus. J Gen Virol 90: 323-333.
5. Sbrana E, Xiao SY, Newman PC, Tesh RB, (2007) Comparative pathology of North American and central African strains of monkeypox virus in a ground squirrel model of the disease. Am J Trop Med Hyg 76: 155-164.
6. Saijo M, Ami Y, Suzaki Y, Nagata N, Iwata N, et al. (2009) Virulence and pathophysiology of the Congo Basin and West African strains of monkeypox virus in non-human primates. J Gen Virol 90: 2266-2271.
7. Sejvar JJ, Chowdary Y, Schomogyi M, Stevens J, Patel J, et al. (2004) Human monkeypox infection: a family cluster in the midwestern United States. J Infect Dis 190: 1833-1840.
8. Gubser C, Hue S, Kellam P, Smith GL, (2004) Poxvirus genomes: a phylogenetic analysis. J Gen Virol 85: 105-117.
9. Hammarlund E, Lewis MW, Carter SV, Amanna I, Hansen SG, et al. (2005) Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nat Med 11: 1005-1011.
10. Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, et al. (2003) Duration of antiviral immunity after smallpox vaccination. Nat Med 9: 1131-1137.
11. Edghill-Smith Y, Golding H, Manischewitz J, King LR, Scott D, et al. (2005) Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat Med 11: 740-747.
12. Panchanathan V, Chaudhri G, Karupiah G, (2006) Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function. J Virol 80: 6333-6338.
13. Belyakov IM, Earl P, Dzutsev A, Kuznetsov VA, Lemon M, et al. (2003) Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc Natl Acad Sci U S A 100: 9458-9463.
14. Snyder JT, Belyakov IM, Dzutsev A, Lemonnier F, Berzofsky JA, (2004) Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses. J Virol 78: 7052-7060.
15. Tscharke DC, Karupiah G, Zhou J, Palmore T, Irvine KR, et al. (2005) Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. J Exp Med 201: 95-104.
16. Grandpre LE, Duke-Cohan JS, Ewald BA, Devoy C, Barouch DH, et al. (2009) Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys. Vaccine 27: 1549-1556.
17. Earl PL, Americo JL, Wyatt LS, Eller LA, Montefiori DC, et al. (2007) Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate. Virology 366: 84-97.
18. Byun M, Verweij MC, Pickup DJ, Wiertz EJ, Hansen TH, et al. (2009) Two mechanistically distinct immune evasion proteins of cowpox virus combine to avoid antiviral CD8 T cells. Cell Host Microbe 6: 422-432.
19. Byun M, Wang X, Pak M, Hansen TH, Yokoyama WM, (2007) Cowpox virus exploits the endoplasmic reticulum retention pathway to inhibit MHC class I transport to the cell surface. Cell Host Microbe 2: 306-315.
20. Alzhanova D, Edwards DM, Hammarlund E, Scholz IG, Horst D, et al. (2009) Cowpox virus inhibits the transporter associated with antigen processing to evade T cell recognition. Cell Host Microbe 6: 433-445.
21. Hammarlund E, Dasgupta A, Frueh K, Slifka MK, (2008) Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation. Proc Natl Acad Sci U S A 105: 14567-72.
22. Dasgupta A, Hammarlund E, Slifka MK, Fruh K, (2007) Cowpox Virus Evades CTL Recognition and Inhibits the Intracellular Transport of MHC Class I Molecules. J Immunol 178: 1654-1661.
23. Loffredo JT, Burwitz BJ, Rakasz EG, Spencer SP, Stephany JJ, et al. (2007) The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape. J Virol 81: 2624-2634.
24. Yang G, Pevear DC, Davies MH, Collett MS, Bailey T, et al. (2005) An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge. J Virol 79: 13139-13149.
25. Lewinsohn DA, Winata E, Swarbrick GM, Tanner KE, Cook MS, et al. (2007) Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B. PLoS Pathog 3: 1240-1249.
26. Heinzel AS, Grotzke JE, Lines RA, Lewinsohn DA, McNabb AL, et al. (2002) HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells. J Exp Med 196: 1473-1481.
27. Estep RD, Messaoudi I, O'Connor MA, Li H, Sprague J, et al. (2011) Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of infection. J Virol 85: 9527-9542.
28. Horst D, Verweij MC, Davison AJ, Ressing ME, Wiertz EJ, (2011) Viral evasion of T cell immunity: ancient mechanisms offering new applications. Curr Opin Immunol 23: 96-103.
29. Alcami A, Lira SA, (2010) Modulation of chemokine activity by viruses. Curr Opin Immunol 22: 482-487.
30. Smith VP, Bryant NA, Alcami A, (2000) Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins. J Gen Virol 81: 1223-1230.
31. Smith GL, Symons JA, Alcami A (1999) Immune modulation by proteins secreted from cells infected by vaccinia virus. Arch Virol Suppl 15:: 111-129.
32. Nash P, Barrett J, Cao JX, Hota-Mitchell S, Lalani AS, et al. (1999) Immunomodulation by viruses: the myxoma virus story. Immunol Rev 168: 103-120.
33. Saraiva M, Smith P, Fallon PG, Alcami A, (2002) Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus. J Exp Med 196: 829-839.
34. Li H, Deetz CO, Zapata JC, Cairo C, Hebbeler AM, et al. (2007) Vaccinia virus inhibits T cell receptor-dependent responses by human gammadelta T cells. J Infect Dis 195: 37-45.
35. Gabaev I, Steinbruck L, Pokoyski C, Pich A, Stanton RJ, et al. (2011) The human cytomegalovirus UL11 protein interacts with the receptor tyrosine phosphatase CD45, resulting in functional paralysis of T cells. PLoS Pathog 7: e1002432.
36. Besold K, Wills M, Plachter B, (2009) Immune evasion proteins gpUS2 and gpUS11 of human cytomegalovirus incompletely protect infected cells from CD8 T cell recognition. Virology 391: 5-19.
37. Huang J, Brameshuber M, Zeng X, Xie J, Li QJ, et al. (2013) A single peptide-major histocompatibility complex ligand triggers digital cytokine secretion in CD4(+) T cells. Immunity 39: 846-857.
38. McGrath MM, Najafian N, (2012) The role of coinhibitory signaling pathways in transplantation and tolerance. Front Immunol 3: 47.
39. Smith GL, McFadden G, (2002) Smallpox: anything to declare? Nat Rev Immunol 2: 521-527.
40. Guerin JL, Gelfi J, Boullier S, Delverdier M, Bellanger FA, et al. (2002) Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins. J Virol 76: 2912-2923.
41. Frebel H, Richter K, Oxenius A, (2010) How chronic viral infections impact on antigen-specific T-cell responses. Eur J Immunol 40: 654-663.
42. Tardif JC, L'Allier PL, Gregoire J, Ibrahim R, McFadden G, et al. (2010) A randomized controlled, phase 2 trial of the viral serpin Serp-1 in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Circ Cardiovasc Interv 3: 543-548.
43. Hruby DE, Guarino LA, Kates JR, (1979) Vaccinia virus replication. I. Requirement for the host-cell nucleus. J Virol 29: 705-715.
44. Altschuler Y, Barbas SM, Terlecky LJ, Tang K, Hardy S, et al. (1998) Redundant and distinct functions for dynamin-1 and dynamin-2 isoforms. J Cell Biol 143: 1871-1881.
45. Streblow DN, Soderberg-Naucler C, Vieira J, Smith P, Wakabayashi E, et al. (1999) The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 99: 511-520.
46. Boyle DB, Coupar BE, (1988) A dominant selectable marker for the construction of recombinant poxviruses. Gene 65: 123-128.
47. Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR, (1989) Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77: 61-68.
48. Cameron CM, Barrett JW, Mann M, Lucas A, McFadden G, (2005) Myxoma virus M128L is expressed as a cell surface CD47-like virulence factor that contributes to the downregulation of macrophage activation in vivo. Virology 337: 55-67.
49. Pickup DJ, Ink BS, Parsons BL, Hu W, Joklik WK, (1984) Spontaneous deletions and duplications of sequences in the genome of cowpox virus. Proc Natl Acad Sci U S A 81: 6817-6821.
50. Panus JF, Smith CA, Ray CA, Smith TD, Patel DD, et al. (2002) Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologue. Proc Natl Acad Sci U S A 99: 8348-8353.
51. Moss B, Elroy-Stein O, Mizukami T, Alexander WA, Fuerst TR, (1990) Product review. New mammalian expression vectors. Nature 348: 91-92.
52. Mackett M, Smith GL, Moss B, (1984) General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol 49: 857-864.
53. Fuerst TR, Earl PL, Moss B, (1987) Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Mol Cell Biol 7: 2538-2544.
54. Vennema H, Rijnbrand R, Heijnen L, Horzinek MC, Spaan WJ, (1991) Enhancement of the vaccinia virus/phage T7 RNA polymerase expression system using encephalomyocarditis virus 5'-untranslated region sequences. Gene 108: 201-209.
55. Smith DB, Corcoran LM (2001) Expression and purification of glutathione-S-transferase fusion proteins. Curr Protoc Mol Biol Chapter 16Unit16 17.
56. Nelson EK, Piehler B, Eckels J, Rauch A, Bellew M, et al. (2011) LabKey Server: an open source platform for scientific data integration, analysis and collaboration. BMC Bioinformatics 12: 71.
57. Lohse M, Bolger AM, Nagel A, Fernie AR, Lunn JE, et al. (2012) RobiNA: a user-friendly, integrated software solution for RNA-Seq-based transcriptomics. Nucleic Acids Res 40: W622-627.
58. Li H, Durbin R, (2010) Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26: 589-595.
59. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, et al. (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078-2079.
60. Stajich JE, Block D, Boulez K, Brenner SE, Chervitz SA, et al. (2002) The Bioperl toolkit: Perl modules for the life sciences. Genome Res 12: 1611-1618.